BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirschfeld M, Rücker G, Weiß D, Berner K, Ritter A, Jäger M, Erbes T. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection. Mol Diagn Ther 2020;24:215-32. [PMID: 32112368 DOI: 10.1007/s40291-020-00453-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Yi X, Huang D, Li Z, Wang X, Yang T, Zhao M, Wu J, Zhong T. The role and application of small extracellular vesicles in breast cancer. Front Oncol 2022;12:980404. [DOI: 10.3389/fonc.2022.980404] [Reference Citation Analysis]
2 Freitas AJAD, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, Souza CDP, Marques MMC. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. IJMS 2022;23:9952. [DOI: 10.3390/ijms23179952] [Reference Citation Analysis]
3 Faraji G, Moeini P, Ranjbar MH. Exosomal microRNAs in breast cancer and their potential in diagnosis, prognosis and treatment prediction. Pathol Res Pract 2022;238:154081. [PMID: 35994809 DOI: 10.1016/j.prp.2022.154081] [Reference Citation Analysis]
4 Meng L, Song K, Li S, Kang Y. Exosomes: Small Vesicles with Important Roles in the Development, Metastasis and Treatment of Breast Cancer. Membranes 2022;12:775. [DOI: 10.3390/membranes12080775] [Reference Citation Analysis]
5 Ashekyan O, Abdallah S, Shoukari AA, Chamandi G, Choubassy H, Itani ARS, Alwan N, Nasr R. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis. IJMS 2022;23:8351. [DOI: 10.3390/ijms23158351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Søiland H, Janssen EAM, Helland T, Eliassen FM, Hagland M, Nordgård O, Lunde S, Lende TH, Sagen JV, Tjensvoll K, Gilje B, Jonsdottir K, Gudlaugsson E, Lode K, Hagen KB, Gripsrud BH, Lind R, Heie A, Aas T, Austdal M, Egeland NG, Bernklev T, Lash TL, Skartveit L, Kroksveen AC, Oltedal S, Kvaløy JT, Lien EA, Sleire L, Mellgren G; PBCB-study group. Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study. BMJ Open 2022;12:e054404. [PMID: 35487718 DOI: 10.1136/bmjopen-2021-054404] [Reference Citation Analysis]
7 Wu HJ, Chu PY. Current and Developing Liquid Biopsy Techniques for Breast Cancer. Cancers (Basel) 2022;14:2052. [PMID: 35565189 DOI: 10.3390/cancers14092052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, Gupta RC, Agrawal AK. Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application. Cancers 2022;14:1435. [DOI: 10.3390/cancers14061435] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
9 Preethi KA, Selvakumar SC, Ross K, Jayaraman S, Tusubira D, Sekar D. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer. Mol Cancer 2022;21:54. [PMID: 35172817 DOI: 10.1186/s12943-022-01525-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Li C, Li R, Hu X, Zhou G, Jiang G. Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression. Breast Cancer Res Treat 2022. [PMID: 35084622 DOI: 10.1007/s10549-021-06433-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Famta P, Shah S, Khatri DK, Guru SK, Singh SB, Srivastava S. Enigmatic role of exosomes in breast cancer progression and therapy. Life Sci 2021;289:120210. [PMID: 34875250 DOI: 10.1016/j.lfs.2021.120210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Pal M, Muinao T, Boruah HPD, Mahindroo N. Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges. Biomed Pharmacother 2021;146:112488. [PMID: 34894516 DOI: 10.1016/j.biopha.2021.112488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yi Y, Wu M, Zeng H, Hu W, Zhao C, Xiong M, Lv W, Deng P, Zhang Q, Wu Y. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer. Front Oncol 2021;11:738945. [PMID: 34707990 DOI: 10.3389/fonc.2021.738945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Patuleia SIS, van der Wall E, van Gils CH, Bakker MF, Jager A, Voorhorst-Ogink MM, van Diest PJ, Moelans CB. The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis. Cell Oncol (Dordr) 2021. [PMID: 34655415 DOI: 10.1007/s13402-021-00641-w] [Reference Citation Analysis]
15 DeLouize AM, Eick G, Karam SD, Snodgrass JJ. Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population-based research. Am J Hum Biol 2021;:e23665. [PMID: 34374148 DOI: 10.1002/ajhb.23665] [Reference Citation Analysis]
16 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles: New Tools for Early Diagnosis of Breast and Genitourinary Cancers. Int J Mol Sci 2021;22:8430. [PMID: 34445131 DOI: 10.3390/ijms22168430] [Reference Citation Analysis]
17 Tito C, De Falco E, Rosa P, Iaiza A, Fazi F, Petrozza V, Calogero A. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes (Basel) 2021;12:1154. [PMID: 34440329 DOI: 10.3390/genes12081154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schröder R, Illert AL, Erbes T, Flotho C, Lübbert M, Duque-Afonso J. The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapy. Epigenetics 2021;:1-13. [PMID: 34159881 DOI: 10.1080/15592294.2021.1940644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pouya FD, Rasmi Y, Gazouli M, Zografos E, Nemati M. MicroRNAs as therapeutic targets in breast cancer metastasis. Drug Deliv Transl Res 2021. [PMID: 33987801 DOI: 10.1007/s13346-021-00999-2] [Reference Citation Analysis]
20 Donkers H, Hirschfeld M, Weiß D, Erbes T, Jäger M, Pijnenborg J, Bekkers R, Galaal K. Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study. Int J Gynecol Cancer 2021;31:868-74. [PMID: 33911004 DOI: 10.1136/ijgc-2021-002494] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Woollam M, Wang L, Grocki P, Liu S, Siegel AP, Kalra M, Goodpaster JV, Yokota H, Agarwal M. Tracking the Progression of Triple Negative Mammary Tumors over Time by Chemometric Analysis of Urinary Volatile Organic Compounds. Cancers (Basel) 2021;13:1462. [PMID: 33806757 DOI: 10.3390/cancers13061462] [Reference Citation Analysis]
22 Piombino C, Mastrolia I, Omarini C, Candini O, Dominici M, Piacentini F, Toss A. The Role of Exosomes in Breast Cancer Diagnosis. Biomedicines 2021;9:312. [PMID: 33803776 DOI: 10.3390/biomedicines9030312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tellez-Gabriel M, Knutsen E, Perander M. Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies. Int J Mol Sci 2020;21:E9457. [PMID: 33322643 DOI: 10.3390/ijms21249457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Li S, Wu Y, Zhang J, Sun H, Wang X. Role of miRNA-424 in Cancers. Onco Targets Ther 2020;13:9611-22. [PMID: 33061443 DOI: 10.2147/OTT.S266541] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Li J, Guan X, Fan Z, Ching LM, Li Y, Wang X, Cao WM, Liu DX. Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers (Basel) 2020;12:E2767. [PMID: 32992445 DOI: 10.3390/cancers12102767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
26 Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Hashemi F, Samarghandian S, Najafi M. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sci 2020;256:117973. [PMID: 32569779 DOI: 10.1016/j.lfs.2020.117973] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]